JPS5811924B2 - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- JPS5811924B2 JPS5811924B2 JP53141779A JP14177978A JPS5811924B2 JP S5811924 B2 JPS5811924 B2 JP S5811924B2 JP 53141779 A JP53141779 A JP 53141779A JP 14177978 A JP14177978 A JP 14177978A JP S5811924 B2 JPS5811924 B2 JP S5811924B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- teeth
- plaque
- adhesion
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title claims description 15
- 229930182830 galactose Natural products 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 8
- 239000002324 mouth wash Substances 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 229940051866 mouthwash Drugs 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 235000015218 chewing gum Nutrition 0.000 claims description 3
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 239000000551 dentifrice Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 208000002064 Dental Plaque Diseases 0.000 description 10
- 210000003296 saliva Anatomy 0.000 description 9
- 239000000606 toothpaste Substances 0.000 description 8
- 229940034610 toothpaste Drugs 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 208000008887 Dental Deposits Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229910000393 dicalcium diphosphate Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940080314 sodium bentonite Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- -1 sucrose fatty acid esters Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Confectionery (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】
本発明は口腔用組成物、さらに詳しくは、歯垢の歯牙付
着を抑制する口腔用組成物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an oral cavity composition, and more particularly to an oral cavity composition that suppresses the adhesion of dental plaque to teeth.
一般に、歯垢は種々の細菌群、細菌の代謝産物唾液成分
などからなる歯牙付着物で、歯垢中の口腔内細菌が産生
する酸や蛋白分解酵素が虫歯や歯槽膿漏の一原因とされ
ている。In general, dental plaque is a dental deposit made up of various bacterial groups, bacterial metabolites, and saliva components, and the acids and proteolytic enzymes produced by oral bacteria in plaque are thought to be a cause of tooth decay and alveolar pyorrhea. ing.
そこで、虫歯や歯槽膿漏の予防、治療には歯垢の除去と
共に、歯垢の歯牙への付着を抑制することが非常に有効
な手段となる。Therefore, in the prevention and treatment of dental caries and alveolar pyorrhea, it is extremely effective to remove dental plaque and to suppress the adhesion of dental plaque to teeth.
本発明者は歯垢の歯牙への付着を抑制する手段について
種々研究を重ねる間に、意外にも、特定の糖類が特異的
に歯垢の歯牙への付着を抑制することを見出した。While carrying out various studies on means for suppressing the adhesion of dental plaque to teeth, the present inventor surprisingly discovered that a specific saccharide specifically suppresses the adhesion of dental plaque to teeth.
すなわち、歯垢の歯牙への付着機構は、まず、唾液成分
が歯牙エナメル質に吸着されてその表面に薄い膜を形成
し、ついで、この膜に口腔内細菌が定着して歯垢の付着
が起こるとされている。In other words, the mechanism by which plaque adheres to teeth is that saliva components are first adsorbed to tooth enamel and form a thin film on its surface, and then oral bacteria colonize this film and prevent plaque from adhering. is said to occur.
該糖はこの口腔内細菌の唾液成分への定着を阻止して歯
垢の歯牙への付着を抑制するものと考えられる。It is thought that the sugar prevents the oral bacteria from colonizing the saliva components and suppresses the adhesion of dental plaque to the teeth.
本発明はかかる知見に基いて完成されたものであって、
活性成分としてガラクトースおよびガラクトースを非還
元末端部に有するオリゴ糖から選ばれる1種または2種
以上の糖を配合してなる口腔用組成物を提供するもので
あり、本発明の組成物は歯垢の歯牙への付着を抑制して
虫歯や歯槽膿漏に対する優れた予防効果を発揮する。The present invention was completed based on such knowledge, and
The present invention provides an oral composition containing one or more sugars selected from galactose and oligosaccharides having galactose at the non-reducing end as an active ingredient. It suppresses the adhesion of fluorophores to the teeth and exhibits an excellent preventive effect against cavities and alveolar pyorrhea.
つぎに各種糖類の、歯垢の歯牙付着に及ぼす影響を試験
した結果を示す。Next, we will show the results of testing the effects of various sugars on the adhesion of dental plaque to teeth.
試験 1
3Hでラベルした歯牙ハイドロキシアパタイト吸着唾液
画分に、ストレプトコッカス・ミチス(Str、m1t
is)またはストレプトコッカス・サンギス(Str、
sanguis)の精秤した乾燥菌体20mgを加え、
ついで、つぎの第1表に示す各種の糖を全量に対する濃
度が50mMとなるように加え、4℃で1時間培養した
。Test 1 Streptococcus mitis (Str, m1t
is) or Streptococcus sanguis (Str,
Add 20 mg of precisely weighed dry bacterial cells of Sanguis sanguis,
Then, various sugars shown in Table 1 below were added at a concentration of 50 mM relative to the total amount, and cultured at 4°C for 1 hour.
培養後、遠心分離により菌体を分離し、数回洗浄して、
菌体の放射能を指標として菌体に吸着された唾液量を測
定した(唾液の吸着量の多い方が菌と結合し、歯垢の歯
牙への付着の多いことを意味する)。After culturing, the bacterial cells were separated by centrifugation, washed several times,
The amount of saliva adsorbed to the bacteria was measured using the radioactivity of the bacteria as an indicator (the greater the amount of saliva adsorbed, the greater the amount of saliva that binds to the bacteria and the greater the amount of plaque adhering to the teeth).
糖を添加せずに同様に処理した対照群の唾液吸着量と糖
添加群の唾液吸着量を比較して各種の吸着阻止%を算出
した。The amount of saliva adsorbed in the control group, which was treated in the same manner without adding sugar, and the amount of saliva adsorbed in the sugar-added group were compared to calculate the adsorption inhibition percentage for each type.
結果を第1表に示す。この結果から明らかなごとく、ガ
ラクトースおよび、ガラクトースを非還元末端部に有す
るオリゴ糖であるラクトースが特異的に唾液の菌体への
吸着を阻止している。The results are shown in Table 1. As is clear from these results, galactose and lactose, which is an oligosaccharide having galactose at its non-reducing end, specifically inhibit adsorption of saliva to bacterial cells.
フラクトースあるいは、通常、湿潤剤として歯磨に用い
られるソルビトールなどにはかかる効果は認められない
。No such effect is observed with fructose or sorbitol, which is commonly used as a humectant in toothpaste.
試験 2
つぎに、ガラクトースおよびラクトースのヒト歯垢の歯
牙付着抑制効果を試験した。Test 2 Next, the effects of galactose and lactose on inhibiting the adhesion of human dental plaque to teeth were tested.
臨床的に健康な口腔状態にある被験者15人(男性、2
2〜30才)を3群(1群、5人)に分け、第1群には
ガラクトース0.1%(重量%、以下同じ)配合洗口剤
(蒸留水溶液)、第2群にはラクトース0.1%配合洗
口剤(蒸留水溶酸)を、第3群は対照群として、プラセ
ボ洗口剤(蒸留水)を、各々、毎日5回、3日間使用さ
せた。15 subjects (male, 2
2 to 30 years old) were divided into three groups (group 1, 5 people), the first group received a mouthwash containing 0.1% galactose (by weight, the same hereinafter) (distilled aqueous solution), and the second group received lactose. A 0.1% compounded mouthwash (distilled water-soluble acid) was used in the third group, and a placebo mouthwash (distilled water) was used in the third group as a control group, 5 times a day for 3 days.
すべての被験者は試験開始前にスケーリングして歯牙の
汚れを除去し、試験中は読口以外の口腔清掃を行なわせ
ないこととした。All subjects had their teeth scaled to remove stains before the start of the test, and were not allowed to perform oral cleaning other than mouth reading during the test.
3日後、歯牙に付着した歯垢をエリスロシンで染色し、
クイグリ−およびバイン〔G、QuigleyおよびJ
、He1n Journalof American
Dental As5ociation、65゜26(
1962)〕の記載するインデックス法に従って歯垢の
歯牙付着状態を評価した。After 3 days, the plaque attached to the teeth was stained with erythrosine.
Quigley and Vine [G, Quigley and J.
, He1n Journal of American
Dental As5ocation, 65°26(
The state of plaque adhesion to teeth was evaluated according to the index method described in [1962].
第3群(対照群)の平均歯垢付着度合を100として、
他の各群の平均歯垢付着度合を算出した。The average degree of plaque adhesion in the third group (control group) was set as 100,
The average degree of plaque adhesion for each other group was calculated.
結果をつぎの第2表に示す。The results are shown in Table 2 below.
第2表に示すごとく、ガラクトースおよびラクトースを
配合した洗口剤はヒトにおける歯垢の歯牙への付着を明
らかに抑制する。As shown in Table 2, mouth rinses containing galactose and lactose clearly inhibit the adhesion of dental plaque to teeth in humans.
かくして、本発明の口腔用組成物にはガラクトースおよ
びガラクトースを非還元末端部にもつオリゴ糖から選ば
れる糖を単独で、あるいは2種以上併用する。Thus, in the oral composition of the present invention, saccharides selected from galactose and oligosaccharides having galactose at the non-reducing end are used alone or in combination of two or more.
用いるオリゴ糖としては、前記のラクトースが好ましい
。As the oligosaccharide to be used, the above-mentioned lactose is preferable.
これらの糖の配合割合はその効果に応じて適宜選択でき
るが、通常、組成物全量に対して0.001〜10%、
好ましくは、0.1〜5%とする。The blending ratio of these sugars can be selected as appropriate depending on the effect, but usually 0.001 to 10%, based on the total amount of the composition.
Preferably, it is 0.1 to 5%.
本発明の口腔用組成物は常法に従って練歯磨、粉歯磨、
液状歯磨などの歯磨類、洗口剤などの口腔洗浄剤、トロ
ーチ、チューインガムなどの剤形にすることができる。The oral composition of the present invention can be prepared using conventional methods such as toothpaste, powdered toothpaste,
It can be made into dosage forms such as dentifrices such as liquid toothpaste, oral cleansers such as mouth rinses, troches, and chewing gums.
他の配合成分は通常用いられるものいずれでもよく、例
えば、歯磨の場合はグリセリン、ソルビトールなどの湿
潤剤、第ニリン酸カルシウム、炭酸カルシウム、無水ケ
イ酸、水酸化アルミニウム、ピロリン酸カルシウム、不
溶性メタリン酸ナトリウムなどの研磨剤、ラウリル硫酸
ナトリウム、アシルサルコシンナトリウム、ショ糖脂肪
酸エステルなどの発泡剤、カルボキシメチルセルロース
ナトリウム、カラギーナン、アルギン酸ナトリウム、ベ
ントナイトなどの粘結剤、甘味料、香料、その他、モノ
フルオロリン酸ナトリウム、各種殺菌剤、抗炎症剤など
の薬効剤が配合される。Other ingredients may be any commonly used ingredients; for example, in the case of toothpaste, wetting agents such as glycerin and sorbitol, calcium diphosphate, calcium carbonate, silicic anhydride, aluminum hydroxide, calcium pyrophosphate, insoluble sodium metaphosphate, etc. abrasives, foaming agents such as sodium lauryl sulfate, sodium acylsarcosinate, and sucrose fatty acid esters, binders such as sodium carboxymethyl cellulose, carrageenan, sodium alginate, and bentonite, sweeteners, flavorings, and others, sodium monofluorophosphate, Contains medicinal agents such as various disinfectants and anti-inflammatory agents.
つぎに実施例を挙げて本発明をさらに詳しく説明する。Next, the present invention will be explained in more detail with reference to Examples.
実施例 1 つぎの処方に従い、常法によって練歯磨を得た。Example 1 Toothpaste was obtained in a conventional manner according to the following recipe.
実施例 2 つぎの処方に従い、常法によって練歯磨を得た。Example 2 Toothpaste was obtained in a conventional manner according to the following recipe.
実施例 3 つぎの処方に従い、常法によって練歯磨を得た。Example 3 Toothpaste was obtained in a conventional manner according to the following recipe.
実施例 4 つぎの処方に従い、常法によって洗口剤を得た。Example 4 A mouthwash was obtained by a conventional method according to the following recipe.
実施例 5 つぎの処方に従い、常法によってトローチ剤を得た。Example 5 A lozenge was obtained by a conventional method according to the following recipe.
実施例 6
つぎの処方に従い、常法によってチューインガムを得た
。Example 6 Chewing gum was obtained in a conventional manner according to the following recipe.
Claims (1)
独で、または併用して配合してなることを特徴とする口
腔用組成物。 2 該糖を組成物全量に対して0.001〜10重量%
配合した前記第1項の組成物。 3 歯磨組成物の剤形である前記第1項または第2項の
組成物。 4 口腔洗浄剤の剤形である前記第1項または第2項の
組成物。 5 トローチの剤形である前記第1項または第2項の組
成物。 6 チューインガムの剤形である前記第1項または第2
項の組成物。[Scope of Claims] 1. An oral composition comprising a sugar selected from galactose and lactose, either alone or in combination. 2 0.001 to 10% by weight of the sugar based on the total amount of the composition
The composition according to item 1 above. 3. The composition of item 1 or 2 above, which is in the form of a dentifrice composition. 4. The composition of item 1 or 2 above, which is in the form of a mouthwash. 5. The composition of item 1 or 2 above, which is in the form of a troche. 6. The above item 1 or 2 which is a chewing gum dosage form.
composition of the term.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53141779A JPS5811924B2 (en) | 1978-11-16 | 1978-11-16 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP53141779A JPS5811924B2 (en) | 1978-11-16 | 1978-11-16 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5569507A JPS5569507A (en) | 1980-05-26 |
| JPS5811924B2 true JPS5811924B2 (en) | 1983-03-05 |
Family
ID=15299965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53141779A Expired JPS5811924B2 (en) | 1978-11-16 | 1978-11-16 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5811924B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03288073A (en) * | 1990-03-30 | 1991-12-18 | Inax Corp | Automatic water discharge device |
| JP2007291084A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291083A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291085A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291086A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| US8834852B2 (en) | 2004-09-29 | 2014-09-16 | Kao Corporation | Composition for oral cavity |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006520382A (en) * | 2003-03-14 | 2006-09-07 | スミスクライン・ビーチャム・コーポレイション | Compositions and methods for prevention of tooth stains |
| US20070166242A1 (en) * | 2005-12-19 | 2007-07-19 | Kross Robert D | Oral care product and method for the reduction of dental caries through inclusion of mannan and galactomannan polysaccharides in dentifrice formulations |
| KR101951024B1 (en) * | 2014-09-24 | 2019-02-21 | 서울대학교산학협력단 | Quorum sensing inhibitor containing d-galactose |
| US20230346670A1 (en) * | 2020-10-02 | 2023-11-02 | Colgate-Palmolive Company | Prebiotic Oral Care Compositions and Methods |
| JP2024025294A (en) * | 2022-08-12 | 2024-02-26 | サンスター株式会社 | Oral composition |
-
1978
- 1978-11-16 JP JP53141779A patent/JPS5811924B2/en not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03288073A (en) * | 1990-03-30 | 1991-12-18 | Inax Corp | Automatic water discharge device |
| US8834852B2 (en) | 2004-09-29 | 2014-09-16 | Kao Corporation | Composition for oral cavity |
| JP2007291084A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291083A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291085A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
| JP2007291086A (en) * | 2006-03-28 | 2007-11-08 | Kao Corp | Oral composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5569507A (en) | 1980-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5104644A (en) | Mouthrinse composition | |
| JP3980645B2 (en) | Anti-caries oral composition | |
| US3897548A (en) | Oral compositions for retarding the formation of dental plaque and methods of utilization thereof | |
| US4096241A (en) | Tooth preparations | |
| Gargouri et al. | Coupling xylitol with remineralizing agents improves tooth protection against demineralization but reduces antibiofilm effect | |
| JPS6326083B2 (en) | ||
| JPH01308219A (en) | Oral cavity composition | |
| JPS5811924B2 (en) | Oral composition | |
| JP4852223B2 (en) | Coaggregation inhibitor of oral bacteria | |
| JPS63277612A (en) | Composition for oral cavity | |
| JPH0424323B2 (en) | ||
| JPH0436228A (en) | Composition for oral cavity application | |
| JPS6216923B2 (en) | ||
| JPS5811927B2 (en) | Oral composition | |
| JP2013523667A (en) | Dental treatment compositions comprising lipoteichoic acids such as mono- or polyglycerophosphoric acids or parts thereof | |
| JP3336688B2 (en) | Oral composition | |
| EP0976380B1 (en) | Method of recalcifying teeth | |
| US6180599B1 (en) | Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease | |
| KR0119269B1 (en) | Composition for improving oral hygiene | |
| FR2838339A1 (en) | Polyphosphonate derivatives useful in toothpastes, mouthwashes, chewing gums and the like for the prevention of dental plaque and caries | |
| García-Godoy et al. | Fluoride dentifrice containing xylitol: in vitro root caries formation | |
| JPH0495020A (en) | Enzyme inhibitor | |
| JPH04120014A (en) | Composition for oral cavity | |
| JP2812496B2 (en) | Antiplaque mouthwash | |
| JPH089529B2 (en) | Oral composition |